Revenue of Pfizer up by 95% for year 2021
Pfizer Inc. reported strong financial results for fourth-quarter and full-year 2021 and provided 2022 total company ...
Read morePfizer Inc. reported strong financial results for fourth-quarter and full-year 2021 and provided 2022 total company ...
Read morePfizer and BioNTech announced that the Conditional MA for COMIRNATY® in the EU has been expanded to ...
Read moreMyovant Sciences and Pfizer announced that the U.S. FDA has approved MYFEMBREE® (relugolix 40 mg, estradiol ...
Read morePfizer Inc. announced that the first enrolled subjects have received their immunizations as part of a ...
Read moreEMA’s human medicines committee (CHMP) has recommended a change to the approved storage conditions of Comirnaty, the ...
Read moreIn a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants ...
Read morePfizer Inc. and BioNTech SE today announced the initiation of a Biologics License Application (BLA) with ...
Read morePfizer Inc. and BioNTech SE today announced the signing of a Memorandum of Understanding (MoU) with ...
Read moreHealth Canada authorized the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years ...
Read morePfizer and BioNTech announced they have submitted a variation to the Conditional Marketing Authorization (CMA) in ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.